Table 1.
Demographic and clinical details for the CSF cohort
| Control group* | D0 group | D1 group | D3 group | D7 group | p value | |
|---|---|---|---|---|---|---|
| N (M/F) | 6 (2/4) | 18 (12/6) | 18 (15/3) | 15 (11/4) | 16 (12/4) | |
| Age (median, range) | 71 (53–85) | 35 (23–54) | 36 (23–48) | 31 (19–66) | 28.5 (19–66) | 0.43 (K-W) |
| Glasgow Coma Scale (median, range) | N/A | 5.5 (3–10) | 5.5 (3–10) | 6.5 (3–10) | 5.5 (3–11) | 0.88 (K-W) |
| Injury Severity Score (median, range) | N/A | 39 (17–50) | 35 (18–59) | 33.5 (17–58) | 34.5 (17–50) | 0.98 (K-W) |
| Glasgow Outcome Scale-Extended (median, range) | N/A | 3 (1–8) | 4 (1–8) | 4 (1–8) | 3.5 (1–8) | 0.97 (K-W) |
* Non-TBI CSF samples were obtained from hydrocephalus patients (without previous TBI) undergoing implantation of ventriculoperitoneal shunts